New York, Jan. 18, 2023 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Endoscopic Submucosal Dissection Market by Product, Indication, End ...

New York, United States, Nov. 15, 2023 (GLOBE NEWSWIRE) -- The Global Endoscopic Submucosal Dissection Market Size is expected to reach USD 542.38 Million By 2032, at a CAGR of 5.4% during the ...

A prospective clinical trial from researchers in Japan shows magnetic-anchor-guided endoscopic submucosal dissection for large early gastric cancer to be a feasible and safe method in humans.

ESD is performed with a thin, flexible endoscope inserted through the mouth or rectum. Using miniature tools, clinicians inject fluid to lift a precancerous or early cancer lesion from surrounding ...

Background: Endoscopic mucosal resection is an established method for treating intramucosal gastric neoplasms. Conventional endoscopic mucosal resection has predominantly been performed using strip ...

Endoscopic submucosal dissection (ESD) represents a significant advance in therapeutic endoscopy with the major advantage being the ability to achieve a higher en bloc resection rate for early stage ...

Incorporation of laparoscopic D2 dissection into the management of gastric adenocarcinoma (GCa) in a community-based setting. Background: Local failure after chemoradiotherapy (CRT) remains a major ...

Open-label phase 1/2 study evaluating the tolerability and antitumor activity of selinexor and pembrolizumab in colorectal cancer. A multicenter phase 2 trial of ramucirumab plus FOLFIRI as ...

Endoscopic submucosal dissection (ESD) of large colorectal adenomas resulted in a lower recurrence rate compared with endoscopic mucosal resection (EMR), but the more technically complex ESD had a ...

Patients with gastric tumors usually present with symptoms of discomfort or pain in the epigastrium, regurgitations, nausea, vomiting or melena. Treatment options include open and laparoscopic total ...